AB Active ETFs Inc. (EYEG) NASDAQ
$34.72 - (-)
Market Cap: $24.31M
As of 04/24/24 12:00 AM EDT. Market closed.
AB Active ETFs Inc. (EYEG)
NASDAQ
$34.72
- (-)
Market Cap: $24.31M
As of 04/24/24 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR AB ACTIVE ETFS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$34.72
Days Range
$34.66 - $34.72
52 week range
$34.52 - $35.71
Volume
300
Avg. Volume (30 days)
1,383
Market Cap
$24.31M
Dividend Yield
1.56%
P/E
-
Shares Outstanding
700,000
Open
-
Previous Close
$34.72
Days Range
$34.66 - $34.72
52 week range
$34.52 - $35.71
Volume
300
Avg. Volume (30 days)
1,383
Market Cap
$24.31M
Dividend Yield
1.56%
P/E
-
Shares Outstanding
700,000
FINANCIAL STATEMENTS FOR AB ACTIVE ETFS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AB ACTIVE ETFS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Strem Brian M. | President and CEO | Mar 03, 2023 | Option Exercise | $3.83 | 15,600 | 59,748 | 28,783 | Mar 07, 2023, 08:15 PM |
| Romano Sarah | Chief Financial Officer | Feb 10, 2022 | Option Exercise | $0.69 | 108 | 75 | 22,746 | Feb 11, 2022, 04:31 PM |
| Romano Sarah | Chief Financial Officer | Jan 05, 2022 | Option Exercise | $1.08 | 114 | 123 | 22,854 | Jan 06, 2022, 05:10 PM |
| FROM STEPHEN | Executive Chairman | Jan 05, 2022 | Option Exercise | $1.08 | 326 | 352 | 67,693 | Jan 06, 2022, 05:10 PM |
| FROM STEPHEN | Executive Chairman | Dec 07, 2021 | Option Exercise | $1.30 | 273 | 355 | 68,019 | Dec 08, 2021, 04:16 PM |
| Romano Sarah | Chief Financial Officer | Dec 07, 2021 | Option Exercise | $1.30 | 91 | 118 | 22,968 | Dec 08, 2021, 04:15 PM |
| Strem Brian M. | President and CEO | Nov 18, 2021 | Buy | $1.41 | 17,853 | 25,173 | 27,370 | Nov 22, 2021, 04:35 PM |
| FROM STEPHEN | Executive Chairman | Nov 02, 2021 | Option Exercise | $1.98 | 250 | 495 | 68,292 | Nov 03, 2021, 04:16 PM |
| Mann Brenda | VP of Research & Development | Nov 02, 2021 | Option Exercise | $1.98 | 62 | 123 | 15,136 | Nov 03, 2021, 04:16 PM |
| Romano Sarah | Chief Financial Officer | Nov 02, 2021 | Option Exercise | $1.98 | 83 | 164 | 23,059 | Nov 03, 2021, 04:15 PM |
| Romano Sarah | Chief Financial Officer | Oct 04, 2021 | Option Exercise | $2.01 | 83 | 167 | 23,142 | Oct 05, 2021, 06:40 PM |
| Mann Brenda | VP of Research & Development | Oct 04, 2021 | Option Exercise | $2.01 | 62 | 125 | 15,198 | Oct 05, 2021, 06:40 PM |
| FROM STEPHEN | Executive Chairman | Oct 04, 2021 | Option Exercise | $2.01 | 249 | 500 | 68,542 | Oct 05, 2021, 06:39 PM |
| FROM STEPHEN | Executive Chairman | Sep 02, 2021 | Option Exercise | $1.81 | 253 | 458 | 68,791 | Sep 03, 2021, 04:17 PM |
| Romano Sarah | Chief Financial Officer | Sep 02, 2021 | Option Exercise | $1.81 | 84 | 152 | 23,225 | Sep 03, 2021, 04:16 PM |
| Mann Brenda | VP of Research & Development | Sep 02, 2021 | Option Exercise | $1.81 | 61 | 110 | 15,260 | Sep 03, 2021, 04:15 PM |
| FROM STEPHEN | Executive Chairman | Aug 03, 2021 | Option Exercise | $2.40 | 261 | 626 | 69,044 | Aug 04, 2021, 05:46 PM |
| MANZO MICHAEL P. | VP of Engineering | Aug 03, 2021 | Option Exercise | $2.40 | 65 | 156 | 15,378 | Aug 04, 2021, 05:46 PM |
| Mann Brenda | VP of Research & Development | Aug 03, 2021 | Option Exercise | $2.40 | 63 | 151 | 15,321 | Aug 04, 2021, 05:45 PM |
| Romano Sarah | Chief Financial Officer | Aug 03, 2021 | Option Exercise | $2.40 | 87 | 209 | 23,309 | Aug 04, 2021, 05:45 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Jul 30, 2021 | Sale | $2.69 | 68,188 | 183,562 | 977,775 | Aug 03, 2021, 05:09 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Aug 02, 2021 | Sale | $2.40 | 192,775 | 463,046 | 785,000 | Aug 03, 2021, 05:09 PM |
| ARMISTICE CAPITAL, LLC | Director | Jul 27, 2021 | Option Exercise | $4.80 | 852,500 | 4,092,000 | 4,199,101 | Jul 29, 2021, 07:59 PM |
| ARMISTICE CAPITAL, LLC | Director | Jul 29, 2021 | Sale | $3.00 | 400,000 | 1,200,000 | 1,045,963 | Jul 29, 2021, 07:59 PM |
| ARMISTICE CAPITAL, LLC | Director | Jul 28, 2021 | Sale | $3.28 | 375,443 | 1,232,617 | 1,445,963 | Jul 29, 2021, 07:59 PM |
| ARMISTICE CAPITAL, LLC | Director | Jul 27, 2021 | Sale | $5.09 | 2,377,695 | 12,113,647 | 4,126,000 | Jul 29, 2021, 07:59 PM |
| Romano Sarah | Chief Financial Officer | Jul 02, 2021 | Option Exercise | $3.70 | 180 | 666 | 23,396 | Jul 06, 2021, 04:32 PM |
| MANZO MICHAEL P. | VP of Engineering | Jul 02, 2021 | Option Exercise | $3.70 | 160 | 592 | 15,443 | Jul 06, 2021, 04:31 PM |
| Mann Brenda | VP of Research & Development | Jul 02, 2021 | Option Exercise | $3.70 | 154 | 570 | 15,384 | Jul 06, 2021, 04:31 PM |
| FROM STEPHEN | Executive Chairman | Jul 02, 2021 | Option Exercise | $3.70 | 877 | 3,245 | 69,305 | Jul 06, 2021, 04:31 PM |
| FROM STEPHEN | Executive Chairman | Jun 04, 2021 | Option Exercise | $4.19 | 878 | 3,679 | 70,182 | Jun 07, 2021, 05:02 PM |
| Romano Sarah | Chief Financial Officer | Jun 04, 2021 | Option Exercise | $4.19 | 180 | 754 | 23,576 | Jun 07, 2021, 05:02 PM |
| MANZO MICHAEL P. | VP of Engineering | Jun 04, 2021 | Option Exercise | $4.19 | 155 | 649 | 15,603 | Jun 07, 2021, 05:01 PM |
| FROM STEPHEN | Executive Chairman | May 04, 2021 | Option Exercise | $4.13 | 889 | 3,672 | 71,060 | May 05, 2021, 09:57 PM |
| Romano Sarah | Chief Financial Officer | May 04, 2021 | Option Exercise | $4.13 | 177 | 731 | 23,756 | May 05, 2021, 09:57 PM |
| MANZO MICHAEL P. | VP of Engineering | May 04, 2021 | Option Exercise | $4.13 | 158 | 653 | 15,758 | May 05, 2021, 09:57 PM |
| Mann Brenda | VP of Research & Development | May 04, 2021 | Option Exercise | $4.13 | 191 | 789 | 15,693 | May 05, 2021, 09:56 PM |
| FROM STEPHEN | Executive Chairman | Apr 08, 2021 | Option Exercise | $4.94 | 899 | 4,441 | 71,949 | Apr 09, 2021, 04:16 PM |
| Romano Sarah | Chief Financial Officer | Apr 08, 2021 | Option Exercise | $4.94 | 180 | 889 | 23,933 | Apr 09, 2021, 04:16 PM |
| MANZO MICHAEL P. | VP of Engineering | Apr 08, 2021 | Option Exercise | $4.94 | 194 | 958 | 15,916 | Apr 09, 2021, 04:16 PM |
| Mann Brenda | VP of Research & Development | Apr 08, 2021 | Option Exercise | $4.94 | 192 | 948 | 15,884 | Apr 09, 2021, 04:15 PM |
| FROM STEPHEN | Executive Chairman | Mar 03, 2021 | Option Exercise | $5.46 | 898 | 4,903 | 72,848 | Mar 05, 2021, 04:31 PM |
| Romano Sarah | Chief Financial Officer | Mar 03, 2021 | Option Exercise | $5.46 | 218 | 1,190 | 24,113 | Mar 05, 2021, 04:31 PM |
| MANZO MICHAEL P. | VP of Engineering | Mar 03, 2021 | Option Exercise | $5.46 | 192 | 1,048 | 16,110 | Mar 05, 2021, 04:31 PM |
| Mann Brenda | VP of Research & Development | Mar 03, 2021 | Option Exercise | $5.46 | 192 | 1,048 | 16,076 | Mar 05, 2021, 04:31 PM |
| MANZO MICHAEL P. | VP of Engineering | Feb 02, 2021 | Option Exercise | $6.34 | 990 | 6,277 | 16,302 | Feb 03, 2021, 09:53 PM |
| Mann Brenda | VP of Research & Development | Feb 02, 2021 | Option Exercise | $6.34 | 988 | 6,264 | 16,268 | Feb 03, 2021, 09:53 PM |
| FROM STEPHEN | Executive Chairman | Feb 02, 2021 | Option Exercise | $6.34 | 3,542 | 22,456 | 73,746 | Feb 03, 2021, 09:53 PM |
| Romano Sarah | Chief Financial Officer | Feb 02, 2021 | Option Exercise | $6.34 | 1,282 | 8,128 | 24,331 | Feb 03, 2021, 09:53 PM |
| ARMISTICE CAPITAL, LLC | Director | Jan 06, 2021 | Buy | $5.22 | 1,531,101 | 8,000,003 | 3,346,601 | Jan 08, 2021, 08:31 PM |
| Mann Brenda | VP of Research & Development | Jan 04, 2021 | Option Exercise | $4.85 | 115 | 558 | 17,256 | Jan 05, 2021, 04:15 PM |
| Romano Sarah | Chief Financial Officer | Jan 04, 2021 | Option Exercise | $4.85 | 115 | 558 | 25,613 | Jan 05, 2021, 12:00 AM |
| FROM STEPHEN | President and CEO | Jan 04, 2021 | Option Exercise | $4.85 | 705 | 3,419 | 77,288 | Jan 05, 2021, 12:00 AM |
| MANZO MICHAEL P. | VP of Engineering | Jan 04, 2021 | Option Exercise | $4.85 | 115 | 558 | 17,292 | Jan 05, 2021, 12:00 AM |
| Mann Brenda | VP of Research & Development | Dec 07, 2020 | Option Exercise | $3.76 | 91 | 342 | 17,371 | Dec 08, 2020, 08:17 PM |
| FROM STEPHEN | President and CEO | Dec 07, 2020 | Option Exercise | $3.76 | 588 | 2,211 | 77,993 | Dec 08, 2020, 08:17 PM |
| MANZO MICHAEL P. | VP of Engineering | Dec 07, 2020 | Option Exercise | $3.76 | 91 | 342 | 17,407 | Dec 08, 2020, 08:17 PM |
| Romano Sarah | Chief Financial Officer | Dec 07, 2020 | Option Exercise | $3.76 | 91 | 342 | 25,728 | Dec 08, 2020, 08:16 PM |
| FROM STEPHEN | President and CEO | Nov 02, 2020 | Option Exercise | $3.51 | 623 | 2,187 | 78,581 | Nov 03, 2020, 04:16 PM |
| Mann Brenda | VP of Research & Development | Nov 02, 2020 | Option Exercise | $3.51 | 96 | 337 | 17,462 | Nov 03, 2020, 04:15 PM |
| Romano Sarah | Chief Financial Officer | Nov 02, 2020 | Option Exercise | $3.51 | 97 | 340 | 25,819 | Nov 03, 2020, 04:15 PM |
| MANZO MICHAEL P. | VP of Engineering | Nov 02, 2020 | Option Exercise | $3.51 | 97 | 340 | 17,498 | Nov 03, 2020, 04:15 PM |
| FROM STEPHEN | President and CEO | Oct 02, 2020 | Option Exercise | $3.88 | 631 | 2,448 | 79,204 | Oct 05, 2020, 05:57 PM |
| MANZO MICHAEL P. | VP of Engineering | Oct 02, 2020 | Option Exercise | $3.88 | 98 | 380 | 17,595 | Oct 05, 2020, 05:57 PM |
| Romano Sarah | Chief Financial Officer | Oct 02, 2020 | Option Exercise | $3.88 | 98 | 380 | 25,916 | Oct 05, 2020, 05:57 PM |
| Mann Brenda | VP of Research & Development | Oct 02, 2020 | Option Exercise | $3.88 | 98 | 380 | 17,558 | Oct 05, 2020, 05:56 PM |
| FROM STEPHEN | President and CEO | Sep 02, 2020 | Option Exercise | $3.94 | 628 | 2,474 | 79,835 | Sep 03, 2020, 05:31 PM |
| Mann Brenda | VP of Research & Development | Sep 02, 2020 | Option Exercise | $3.94 | 97 | 382 | 17,656 | Sep 03, 2020, 05:31 PM |
| MANZO MICHAEL P. | VP of Engineering | Sep 02, 2020 | Option Exercise | $3.94 | 97 | 382 | 17,693 | Sep 03, 2020, 05:30 PM |
| Romano Sarah | Chief Financial Officer | Sep 02, 2020 | Option Exercise | $3.94 | 97 | 382 | 26,014 | Sep 03, 2020, 05:30 PM |
| Romano Sarah | Chief Financial Officer | Aug 04, 2020 | Option Exercise | $4.11 | 95 | 390 | 26,111 | Aug 05, 2020, 05:12 PM |
| FROM STEPHEN | President and CEO | Aug 04, 2020 | Option Exercise | $4.11 | 615 | 2,528 | 80,463 | Aug 05, 2020, 05:12 PM |
| MANZO MICHAEL P. | VP of Engineering | Aug 04, 2020 | Option Exercise | $4.11 | 95 | 390 | 17,790 | Aug 05, 2020, 05:11 PM |
| Mann Brenda | VP of Research & Development | Aug 04, 2020 | Option Exercise | $4.11 | 92 | 378 | 17,753 | Aug 05, 2020, 05:11 PM |
| FROM STEPHEN | President and CEO | Jul 02, 2020 | Option Exercise | $4.82 | 625 | 3,013 | 81,078 | Jul 06, 2020, 04:16 PM |
| MANZO MICHAEL P. | VP of Engineering | Jul 02, 2020 | Option Exercise | $4.82 | 97 | 468 | 17,885 | Jul 06, 2020, 04:16 PM |
| Romano Sarah | Chief Financial Officer | Jul 02, 2020 | Option Exercise | $4.82 | 97 | 468 | 26,206 | Jul 06, 2020, 04:15 PM |
| Mann Brenda | VP of Research & Development | Jul 02, 2020 | Option Exercise | $4.82 | 94 | 453 | 17,845 | Jul 06, 2020, 04:15 PM |
| FROM STEPHEN | President and CEO | Jun 03, 2020 | Option Exercise | $5.11 | 627 | 3,204 | 81,703 | Jun 04, 2020, 04:18 PM |
| Romano Sarah | Chief Financial Officer | Jun 03, 2020 | Option Exercise | $5.11 | 94 | 480 | 26,303 | Jun 04, 2020, 04:17 PM |
| Mann Brenda | VP of Research & Development | Jun 03, 2020 | Option Exercise | $5.11 | 94 | 480 | 17,939 | Jun 04, 2020, 04:17 PM |
| MANZO MICHAEL P. | VP of Engineering | Jun 03, 2020 | Option Exercise | $5.11 | 94 | 480 | 17,982 | Jun 04, 2020, 04:16 PM |
| Romano Sarah | Chief Financial Officer | May 05, 2020 | Option Exercise | $5.10 | 93 | 474 | 26,397 | May 06, 2020, 04:31 PM |
| Mann Brenda | VP of Research & Development | May 05, 2020 | Option Exercise | $5.10 | 113 | 576 | 18,033 | May 06, 2020, 04:31 PM |
| MANZO MICHAEL P. | VP of Engineering | May 05, 2020 | Option Exercise | $5.10 | 93 | 474 | 18,076 | May 06, 2020, 04:31 PM |
| FROM STEPHEN | President and CEO | May 05, 2020 | Option Exercise | $5.10 | 617 | 3,147 | 82,330 | May 06, 2020, 04:30 PM |
| Mann Brenda | VP of Research & Development | Apr 02, 2020 | Option Exercise | $4.97 | 122 | 606 | 18,146 | Apr 03, 2020, 05:56 PM |
| FROM STEPHEN | President and CEO | Apr 02, 2020 | Option Exercise | $4.97 | 670 | 3,330 | 82,947 | Apr 03, 2020, 05:55 PM |
| MANZO MICHAEL P. | VP of Engineering | Apr 02, 2020 | Option Exercise | $4.97 | 122 | 606 | 18,169 | Apr 03, 2020, 05:55 PM |
| Romano Sarah | Chief Financial Officer | Apr 02, 2020 | Option Exercise | $4.97 | 122 | 606 | 26,490 | Apr 03, 2020, 05:54 PM |
| FROM STEPHEN | President and CEO | Mar 09, 2020 | Option Exercise | $5.00 | 712 | 3,560 | 83,617 | Mar 10, 2020, 07:13 PM |
| Mann Brenda | VP of Research & Development | Mar 09, 2020 | Option Exercise | $5.00 | 130 | 650 | 18,268 | Mar 10, 2020, 07:13 PM |
| MANZO MICHAEL P. | VP of Engineering | Mar 09, 2020 | Option Exercise | $5.01 | 130 | 651 | 18,291 | Mar 10, 2020, 07:12 PM |
| Romano Sarah | Chief Financial Officer | Mar 09, 2020 | Option Exercise | $5.01 | 130 | 651 | 26,612 | Mar 10, 2020, 07:12 PM |
| ARMISTICE CAPITAL, LLC | Director | Feb 10, 2020 | Buy | $6.04 | 12,000 | 72,480 | 1,815,500 | Feb 10, 2020, 05:45 PM |
| ARMISTICE CAPITAL, LLC | Director | Feb 06, 2020 | Buy | $6.18 | 11,000 | 67,980 | 1,803,500 | Feb 10, 2020, 05:45 PM |
| FROM STEPHEN | President and CEO | Feb 04, 2020 | Option Exercise | $6.00 | 584 | 3,504 | 64,329 | Feb 05, 2020, 05:09 PM |
| MANZO MICHAEL P. | VP of Engineering | Feb 04, 2020 | Option Exercise | $6.00 | 109 | 654 | 10,921 | Feb 05, 2020, 05:04 PM |
| Mann Brenda | VP of Research & Development | Feb 04, 2020 | Option Exercise | $6.00 | 109 | 654 | 10,898 | Feb 05, 2020, 05:02 PM |
| Romano Sarah | Chief Financial Officer | Feb 04, 2020 | Option Exercise | $6.00 | 109 | 654 | 16,742 | Feb 05, 2020, 05:00 PM |
| FROM STEPHEN | President and CEO | Jan 03, 2020 | Option Exercise | $9.52 | 730 | 6,950 | 64,913 | Jan 06, 2020, 05:48 PM |
| Mann Brenda | VP of Research & Development | Jan 03, 2020 | Option Exercise | $9.52 | 119 | 1,133 | 11,007 | Jan 06, 2020, 05:48 PM |
| Romano Sarah | Chief Financial Officer | Jan 03, 2020 | Option Exercise | $9.52 | 119 | 1,133 | 16,851 | Jan 06, 2020, 05:47 PM |
| MANZO MICHAEL P. | VP of Engineering | Jan 03, 2020 | Option Exercise | $9.52 | 119 | 1,133 | 11,030 | Jan 06, 2020, 05:47 PM |
| Romano Sarah | Chief Financial Officer | Dec 18, 2019 | Option Exercise | $7.46 | 101 | 753 | 16,970 | Dec 20, 2019, 05:28 PM |
| Mann Brenda | VP of Research & Development | Dec 18, 2019 | Option Exercise | $7.46 | 101 | 753 | 11,126 | Dec 20, 2019, 05:28 PM |
| MANZO MICHAEL P. | VP of Engineering | Dec 18, 2019 | Option Exercise | $7.46 | 101 | 753 | 11,149 | Dec 20, 2019, 05:27 PM |
| FROM STEPHEN | President and CEO | Dec 18, 2019 | Option Exercise | $7.46 | 653 | 4,871 | 65,643 | Dec 20, 2019, 05:27 PM |
| GOLDBERG MORTON | Director | Dec 06, 2019 | Sale | $6.93 | 1,961 | 13,590 | 0 | Dec 06, 2019, 06:45 PM |
| GOLDBERG MORTON | Director | Nov 12, 2019 | Sale | $4.29 | 2,001 | 8,584 | 1,961 | Nov 13, 2019, 04:18 PM |
| Mann Brenda | VP of Research & Development | Nov 05, 2019 | Option Exercise | $3.85 | 107 | 412 | 11,227 | Nov 07, 2019, 04:15 PM |
| Romano Sarah | Chief Financial Officer | Nov 05, 2019 | Option Exercise | $3.85 | 108 | 416 | 17,071 | Nov 07, 2019, 04:15 PM |
| FROM STEPHEN | President and CEO | Nov 05, 2019 | Option Exercise | $3.85 | 670 | 2,579 | 66,296 | Nov 07, 2019, 04:15 PM |
| MANZO MICHAEL P. | VP of Engineering | Nov 05, 2019 | Option Exercise | $3.86 | 108 | 417 | 11,250 | Nov 07, 2019, 04:15 PM |
| Romano Sarah | Chief Financial Officer | Oct 09, 2019 | Option Exercise | $3.10 | 185 | 573 | 17,179 | Oct 11, 2019, 04:06 PM |
| FROM STEPHEN | President and CEO | Oct 09, 2019 | Option Exercise | $2.95 | 1,184 | 3,493 | 66,966 | Oct 11, 2019, 04:06 PM |
| Mann Brenda | VP of Research & Development | Oct 09, 2019 | Option Exercise | $3.12 | 184 | 574 | 11,334 | Oct 11, 2019, 04:06 PM |
| MANZO MICHAEL P. | VP of Engineering | Oct 09, 2019 | Option Exercise | $3.13 | 185 | 579 | 11,358 | Oct 11, 2019, 04:06 PM |
| ARMISTICE CAPITAL, LLC | Director | Sep 30, 2019 | Buy | $3.12 | 5,001 | 15,613 | 1,792,500 | Oct 01, 2019, 07:53 PM |
| ARMISTICE CAPITAL, LLC | Director | Sep 29, 2019 | Buy | $3.13 | 600,000 | 1,875,000 | 1,787,499 | Oct 01, 2019, 07:53 PM |
| FROM STEPHEN | President and CEO | Aug 06, 2019 | Option Exercise | $0.21 | 10,206 | 2,143 | 1,022,259 | Aug 07, 2019, 07:21 PM |
| Romano Sarah | Chief Financial Officer | Aug 06, 2019 | Option Exercise | $0.21 | 1,649 | 346 | 260,464 | Aug 07, 2019, 07:21 PM |
| MANZO MICHAEL P. | VP of Engineering | Aug 06, 2019 | Option Exercise | $0.21 | 1,649 | 346 | 173,147 | Aug 07, 2019, 07:21 PM |
| Mann Brenda | VP of Research & Development | Aug 06, 2019 | Option Exercise | $0.21 | 1,641 | 345 | 172,783 | Aug 07, 2019, 07:21 PM |
| Wirostko Barbara | Chief Medical Officer | Aug 06, 2019 | Option Exercise | $0.21 | 1,641 | 345 | 403,893 | Aug 07, 2019, 07:20 PM |
| Romano Sarah | Chief Financial Officer | Jul 15, 2019 | Sale | $0.23 | 6,584 | 1,534 | 262,113 | Jul 15, 2019, 08:39 PM |
| Romano Sarah | Chief Financial Officer | Jul 12, 2019 | Sale | $0.24 | 6,583 | 1,551 | 268,697 | Jul 15, 2019, 08:39 PM |
| Romano Sarah | Chief Financial Officer | Jul 11, 2019 | Sale | $0.24 | 6,583 | 1,584 | 275,280 | Jul 15, 2019, 08:39 PM |
| MANZO MICHAEL P. | VP of Engineering | Jul 15, 2019 | Sale | $0.23 | 6,584 | 1,534 | 174,796 | Jul 15, 2019, 08:38 PM |
| MANZO MICHAEL P. | VP of Engineering | Jul 12, 2019 | Sale | $0.24 | 6,583 | 1,551 | 181,380 | Jul 15, 2019, 08:38 PM |
| MANZO MICHAEL P. | VP of Engineering | Jul 11, 2019 | Sale | $0.24 | 6,583 | 1,584 | 187,963 | Jul 15, 2019, 08:38 PM |
| Wirostko Barbara | Chief Medical Officer | Jul 15, 2019 | Sale | $0.23 | 6,488 | 1,512 | 405,534 | Jul 15, 2019, 08:38 PM |
| Wirostko Barbara | Chief Medical Officer | Jul 12, 2019 | Sale | $0.24 | 6,488 | 1,529 | 412,022 | Jul 15, 2019, 08:38 PM |
| Wirostko Barbara | Chief Medical Officer | Jul 11, 2019 | Sale | $0.24 | 6,487 | 1,561 | 418,510 | Jul 15, 2019, 08:38 PM |
| FROM STEPHEN | President and CEO | Jul 15, 2019 | Sale | $0.23 | 42,452 | 9,891 | 1,032,465 | Jul 15, 2019, 08:37 PM |
| FROM STEPHEN | President and CEO | Jul 12, 2019 | Sale | $0.24 | 42,452 | 10,002 | 1,074,917 | Jul 15, 2019, 08:37 PM |
| FROM STEPHEN | President and CEO | Jul 11, 2019 | Sale | $0.24 | 42,451 | 10,214 | 1,117,369 | Jul 15, 2019, 08:37 PM |
| Mann Brenda | VP of Research & Development | Jul 15, 2019 | Sale | $0.23 | 6,350 | 1,480 | 174,424 | Jul 15, 2019, 08:37 PM |
| Mann Brenda | VP of Research & Development | Jul 12, 2019 | Sale | $0.24 | 6,350 | 1,496 | 180,774 | Jul 15, 2019, 08:37 PM |
| Mann Brenda | VP of Research & Development | Jul 11, 2019 | Sale | $0.24 | 6,349 | 1,528 | 187,124 | Jul 15, 2019, 08:37 PM |
| ARMISTICE CAPITAL, LLC | Director | Mar 29, 2019 | Buy | $0.31 | 298,189 | 92,439 | 17,812,500 | Mar 29, 2019, 06:19 PM |
| ARMISTICE CAPITAL, LLC | Director | Mar 28, 2019 | Buy | $0.31 | 130,811 | 40,551 | 17,514,311 | Mar 29, 2019, 06:19 PM |
| ARMISTICE CAPITAL, LLC | Director | Mar 27, 2019 | Buy | $0.35 | 120,647 | 42,226 | 17,383,500 | Mar 29, 2019, 06:19 PM |
| ARMISTICE CAPITAL, LLC | Director | Dec 11, 2018 | Buy | $0.41 | 30,953 | 12,842 | 17,262,853 | Dec 12, 2018, 05:23 PM |
| ARMISTICE CAPITAL, LLC | Director | Dec 10, 2018 | Buy | $0.40 | 69,400 | 27,474 | 17,231,900 | Dec 12, 2018, 05:23 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 16, 2018 | Buy | $0.47 | 178,136 | 83,724 | 17,162,500 | Nov 16, 2018, 07:14 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 15, 2018 | Buy | $0.43 | 126,735 | 55,003 | 16,984,364 | Nov 16, 2018, 07:14 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 14, 2018 | Buy | $0.41 | 55,129 | 22,668 | 16,857,629 | Nov 16, 2018, 07:14 PM |
| Wirostko Barbara | Chief Medical Officer | Jun 08, 2018 | Option Exercise | $0.54 | 7,000 | 3,780 | 59,915 | Jun 13, 2018, 04:32 PM |
| Wirostko Barbara | Chief Medical Officer | Jun 07, 2018 | Option Exercise | $0.52 | 9,600 | 4,992 | 249,997 | Jun 13, 2018, 04:32 PM |
| Wirostko Barbara | Chief Medical Officer | Jun 07, 2018 | Option Exercise | $0.52 | 2,215 | 1,152 | 52,915 | Jun 13, 2018, 04:32 PM |
| Wirostko Barbara | Chief Medical Officer | Jun 08, 2018 | Option Exercise | $0.54 | 7,000 | 3,780 | 249,612 | Jun 11, 2018, 08:37 PM |
| Wirostko Barbara | Chief Medical Officer | Jun 07, 2018 | Option Exercise | $0.52 | 2,215 | 1,152 | 242,612 | Jun 11, 2018, 08:37 PM |
| ARMISTICE CAPITAL, LLC | Director | May 29, 2018 | Buy | $0.57 | 40,700 | 23,317 | 16,802,500 | May 30, 2018, 06:05 PM |
| ARMISTICE CAPITAL, LLC | Director | May 25, 2018 | Buy | $0.58 | 17,575 | 10,116 | 16,761,800 | May 30, 2018, 06:05 PM |
| ARMISTICE CAPITAL, LLC | Director | May 18, 2018 | Buy | $0.56 | 1,725 | 959 | 16,744,225 | May 22, 2018, 05:40 PM |
| ARMISTICE CAPITAL, LLC | Director | May 14, 2018 | Buy | $0.53 | 15,758 | 8,417 | 16,742,500 | May 16, 2018, 05:54 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 11, 2018 | Buy | $0.54 | 49,142 | 26,438 | 16,726,742 | May 11, 2018, 06:02 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 10, 2018 | Buy | $0.54 | 23,917 | 12,982 | 16,677,600 | May 11, 2018, 06:02 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 09, 2018 | Buy | $0.50 | 103,953 | 51,571 | 16,653,683 | May 11, 2018, 06:02 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 08, 2018 | Buy | $0.48 | 37,230 | 17,718 | 16,549,730 | May 08, 2018, 06:22 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 07, 2018 | Buy | $0.48 | 14,252 | 6,888 | 16,512,500 | May 08, 2018, 06:22 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | May 04, 2018 | Buy | $0.45 | 85,748 | 38,866 | 16,498,248 | May 08, 2018, 06:22 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 25, 2018 | Buy | $0.54 | 85,522 | 46,250 | 16,332,500 | Apr 27, 2018, 05:54 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 26, 2018 | Buy | $0.54 | 80,000 | 43,016 | 16,412,500 | Apr 27, 2018, 05:54 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 20, 2018 | Buy | $0.53 | 496,304 | 261,701 | 16,246,978 | Apr 20, 2018, 05:38 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 19, 2018 | Buy | $0.48 | 1,256,920 | 599,299 | 15,750,674 | Apr 20, 2018, 05:38 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 18, 2018 | Buy | $0.47 | 781,254 | 370,158 | 14,493,754 | Apr 20, 2018, 05:38 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 13, 2018 | Buy | $0.33 | 7,425,193 | 2,466,649 | 10,657,723 | Apr 17, 2018, 09:59 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 17, 2018 | Buy | $0.44 | 1,895,610 | 837,670 | 13,712,500 | Apr 17, 2018, 09:59 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Apr 16, 2018 | Buy | $0.38 | 1,159,167 | 435,731 | 11,816,890 | Apr 17, 2018, 09:59 PM |
| Romano Sarah | Chief Financial Officer | Dec 29, 2017 | Option Exercise | $1.01 | 11,863 | 11,982 | 44,363 | Jan 03, 2018, 04:10 PM |
| Wirostko Barbara | Chief Medical Officer | Dec 29, 2017 | Option Exercise | $1.01 | 12,355 | 12,479 | 240,397 | Jan 03, 2018, 04:07 PM |
| Mann Brenda | VP of Research & Development | Dec 29, 2017 | Option Exercise | $1.01 | 6,722 | 6,789 | 18,473 | Jan 03, 2018, 04:07 PM |
| FROM STEPHEN | President and CEO | Dec 29, 2017 | Option Exercise | $1.01 | 12,355 | 12,479 | 284,820 | Jan 03, 2018, 04:05 PM |
| Garanzini Michael | Chief Commercial Officer | Nov 17, 2017 | Option Exercise | $1.07 | 15,000 | 16,050 | 15,000 | Nov 22, 2017, 04:15 PM |
| Wirostko Barbara | Chief Medical Officer | Sep 14, 2017 | Option Exercise | $1.23 | 9,000 | 11,070 | 50,700 | Sep 15, 2017, 04:29 PM |
| Wirostko Barbara | Chief Medical Officer | Sep 14, 2017 | Option Exercise | $1.22 | 1,200 | 1,464 | 219,042 | Sep 15, 2017, 04:29 PM |
| Wirostko Barbara | Chief Medical Officer | Sep 15, 2017 | Option Exercise | $1.20 | 9,000 | 10,800 | 228,042 | Sep 15, 2017, 04:29 PM |
| Romano Sarah | Interim CFO | Aug 15, 2017 | Buy | $1.00 | 10,000 | 10,000 | 32,500 | Aug 17, 2017, 04:05 PM |
| FROM STEPHEN | President and CEO | Aug 10, 2017 | Buy | $1.03 | 12,500 | 12,875 | 272,465 | Aug 10, 2017, 05:57 PM |
| CHANEY PAUL G | Director | Jun 02, 2017 | Option Exercise | $0.65 | 17,570 | 11,420 | 41,229 | Jun 05, 2017, 07:41 PM |
| MANZO MICHAEL P. | Vice President of Engineering | May 15, 2017 | Option Exercise | $0.65 | 7,285 | 4,735 | 19,546 | May 15, 2017, 04:51 PM |
| Ventech Capital II | 10% Owner | Mar 13, 2017 | Sale | $2.80 | 4,419 | 12,385 | 1,431,814 | Mar 21, 2017, 04:47 PM |
| Wirostko Barbara | Chief Medical Officer | Mar 07, 2017 | Option Exercise | $2.83 | 8,700 | 24,621 | 217,842 | Mar 07, 2017, 05:52 PM |
| GOLDBERG MORTON | Director | Mar 06, 2017 | Sale | $3.00 | 8,919 | 26,757 | 9,441 | Mar 06, 2017, 04:05 PM |
| Wirostko Barbara | Chief Medical Officer | Feb 28, 2017 | Option Exercise | $2.60 | 41,700 | 108,420 | 41,700 | Mar 01, 2017, 05:25 PM |
| Wirostko Barbara | Chief Medical Officer | Feb 28, 2017 | Option Exercise | $2.59 | 54,200 | 140,378 | 209,142 | Mar 01, 2017, 05:25 PM |
| GOLDBERG MORTON | Director | Feb 27, 2017 | Option Exercise | $1.70 | 1,083 | 1,841 | 18,360 | Mar 01, 2017, 05:24 PM |
| FROM STEPHEN | President and CEO | Sep 15, 2016 | Buy | $1.49 | 15,000 | 22,338 | 139,965 | Sep 16, 2016, 04:15 PM |
| FROM STEPHEN | President and CEO | Jun 30, 2016 | Option Exercise | $0.65 | 52,990 | 34,327 | 124,965 | Jul 05, 2016, 04:11 PM |
| GOLDBERG MORTON | Director | Jun 15, 2016 | Sale | $3.16 | 15,000 | 47,361 | 17,277 | Jun 15, 2016, 05:10 PM |
| Ventech Capital II | 10% Owner | Jun 10, 2016 | Sale | $3.00 | 15,433 | 46,333 | 1,593,540 | Jun 10, 2016, 04:21 PM |
| Ventech Capital II | 10% Owner | Jun 09, 2016 | Sale | $3.08 | 13,167 | 40,523 | 1,608,973 | Jun 10, 2016, 04:21 PM |
| Ventech Capital II | 10% Owner | Jun 06, 2016 | Sale | $3.27 | 10,000 | 32,684 | 1,641,540 | Jun 09, 2016, 04:29 PM |
| Ventech Capital II | 10% Owner | Jun 08, 2016 | Sale | $3.20 | 2,400 | 7,680 | 1,622,140 | Jun 09, 2016, 04:29 PM |
| Ventech Capital II | 10% Owner | Jun 07, 2016 | Sale | $3.24 | 17,000 | 55,060 | 1,624,540 | Jun 09, 2016, 04:29 PM |
| GOLDBERG MORTON | Director | Jun 03, 2016 | Option Exercise | $0.65 | 33,775 | 21,879 | 43,216 | Jun 07, 2016, 05:42 PM |
| GOLDBERG MORTON | Director | Jun 07, 2016 | Sale | $3.31 | 746 | 2,473 | 32,277 | Jun 07, 2016, 05:42 PM |
| GOLDBERG MORTON | Director | Jun 06, 2016 | Sale | $3.25 | 5,543 | 18,040 | 33,023 | Jun 07, 2016, 05:42 PM |
| GOLDBERG MORTON | Director | Jun 03, 2016 | Sale | $3.37 | 4,650 | 15,690 | 38,566 | Jun 07, 2016, 05:42 PM |
| CHANEY PAUL G | Director | Feb 19, 2015 | Buy | $6.00 | 8,333 | 49,998 | 8,333 | Feb 23, 2015, 05:47 PM |
| Ventech Capital II | 10% Owner | Feb 19, 2015 | Option Exercise | $4.20 | 241,270 | 1,013,334 | 1,391,456 | Feb 23, 2015, 05:41 PM |
| Ventech Capital II | 10% Owner | Feb 19, 2015 | Buy | $6.00 | 102,777 | 616,662 | 1,494,233 | Feb 23, 2015, 05:41 PM |
| NATIXIS PRIVATE EQUITY | 10% Owner | Feb 19, 2015 | Option Exercise | $4.20 | 97,641 | 410,092 | 674,205 | Feb 23, 2015, 05:39 PM |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% Owner | Feb 19, 2015 | Option Exercise | $4.20 | 138,194 | 580,415 | 1,093,812 | Feb 23, 2015, 05:33 PM |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% Owner | Feb 19, 2015 | Buy | $6.00 | 366,667 | 2,200,002 | 1,460,479 | Feb 23, 2015, 05:33 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Strem Brian M. | President and CEO | 03/03/2023 | 59,748 |
| Romano Sarah | Chief Financial Officer | 02/10/2022 | 75 |
| Romano Sarah | Chief Financial Officer | 01/05/2022 | 123 |
| FROM STEPHEN | Executive Chairman | 01/05/2022 | 352 |
| FROM STEPHEN | Executive Chairman | 12/07/2021 | 355 |
| Romano Sarah | Chief Financial Officer | 12/07/2021 | 118 |
| Strem Brian M. | President and CEO | 11/18/2021 | 25,173 |
| FROM STEPHEN | Executive Chairman | 11/02/2021 | 495 |
| Mann Brenda | VP of Research & Development | 11/02/2021 | 123 |
| Romano Sarah | Chief Financial Officer | 11/02/2021 | 164 |
| Romano Sarah | Chief Financial Officer | 10/04/2021 | 167 |
| Mann Brenda | VP of Research & Development | 10/04/2021 | 125 |
| FROM STEPHEN | Executive Chairman | 10/04/2021 | 500 |
| FROM STEPHEN | Executive Chairman | 09/02/2021 | 458 |
| Romano Sarah | Chief Financial Officer | 09/02/2021 | 152 |
| Mann Brenda | VP of Research & Development | 09/02/2021 | 110 |
| FROM STEPHEN | Executive Chairman | 08/03/2021 | 626 |
| MANZO MICHAEL P. | VP of Engineering | 08/03/2021 | 156 |
| Mann Brenda | VP of Research & Development | 08/03/2021 | 151 |
| Romano Sarah | Chief Financial Officer | 08/03/2021 | 209 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 07/30/2021 | 183,562 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 08/02/2021 | 463,046 |
| ARMISTICE CAPITAL, LLC | Director | 07/27/2021 | 4,092,000 |
| ARMISTICE CAPITAL, LLC | Director | 07/29/2021 | 1,200,000 |
| ARMISTICE CAPITAL, LLC | Director | 07/28/2021 | 1,232,617 |
| ARMISTICE CAPITAL, LLC | Director | 07/27/2021 | 12,113,647 |
| Romano Sarah | Chief Financial Officer | 07/02/2021 | 666 |
| MANZO MICHAEL P. | VP of Engineering | 07/02/2021 | 592 |
| Mann Brenda | VP of Research & Development | 07/02/2021 | 570 |
| FROM STEPHEN | Executive Chairman | 07/02/2021 | 3,245 |
| FROM STEPHEN | Executive Chairman | 06/04/2021 | 3,679 |
| Romano Sarah | Chief Financial Officer | 06/04/2021 | 754 |
| MANZO MICHAEL P. | VP of Engineering | 06/04/2021 | 649 |
| FROM STEPHEN | Executive Chairman | 05/04/2021 | 3,672 |
| Romano Sarah | Chief Financial Officer | 05/04/2021 | 731 |
| MANZO MICHAEL P. | VP of Engineering | 05/04/2021 | 653 |
| Mann Brenda | VP of Research & Development | 05/04/2021 | 789 |
| FROM STEPHEN | Executive Chairman | 04/08/2021 | 4,441 |
| Romano Sarah | Chief Financial Officer | 04/08/2021 | 889 |
| MANZO MICHAEL P. | VP of Engineering | 04/08/2021 | 958 |
| Mann Brenda | VP of Research & Development | 04/08/2021 | 948 |
| FROM STEPHEN | Executive Chairman | 03/03/2021 | 4,903 |
| Romano Sarah | Chief Financial Officer | 03/03/2021 | 1,190 |
| MANZO MICHAEL P. | VP of Engineering | 03/03/2021 | 1,048 |
| Mann Brenda | VP of Research & Development | 03/03/2021 | 1,048 |
| MANZO MICHAEL P. | VP of Engineering | 02/02/2021 | 6,277 |
| Mann Brenda | VP of Research & Development | 02/02/2021 | 6,264 |
| FROM STEPHEN | Executive Chairman | 02/02/2021 | 22,456 |
| Romano Sarah | Chief Financial Officer | 02/02/2021 | 8,128 |
| ARMISTICE CAPITAL, LLC | Director | 01/06/2021 | 8,000,003 |
| Mann Brenda | VP of Research & Development | 01/04/2021 | 558 |
| Romano Sarah | Chief Financial Officer | 01/04/2021 | 558 |
| FROM STEPHEN | President and CEO | 01/04/2021 | 3,419 |
| MANZO MICHAEL P. | VP of Engineering | 01/04/2021 | 558 |
| Mann Brenda | VP of Research & Development | 12/07/2020 | 342 |
| FROM STEPHEN | President and CEO | 12/07/2020 | 2,211 |
| MANZO MICHAEL P. | VP of Engineering | 12/07/2020 | 342 |
| Romano Sarah | Chief Financial Officer | 12/07/2020 | 342 |
| FROM STEPHEN | President and CEO | 11/02/2020 | 2,187 |
| Mann Brenda | VP of Research & Development | 11/02/2020 | 337 |
| Romano Sarah | Chief Financial Officer | 11/02/2020 | 340 |
| MANZO MICHAEL P. | VP of Engineering | 11/02/2020 | 340 |
| FROM STEPHEN | President and CEO | 10/02/2020 | 2,448 |
| MANZO MICHAEL P. | VP of Engineering | 10/02/2020 | 380 |
| Romano Sarah | Chief Financial Officer | 10/02/2020 | 380 |
| Mann Brenda | VP of Research & Development | 10/02/2020 | 380 |
| FROM STEPHEN | President and CEO | 09/02/2020 | 2,474 |
| Mann Brenda | VP of Research & Development | 09/02/2020 | 382 |
| MANZO MICHAEL P. | VP of Engineering | 09/02/2020 | 382 |
| Romano Sarah | Chief Financial Officer | 09/02/2020 | 382 |
| Romano Sarah | Chief Financial Officer | 08/04/2020 | 390 |
| FROM STEPHEN | President and CEO | 08/04/2020 | 2,528 |
| MANZO MICHAEL P. | VP of Engineering | 08/04/2020 | 390 |
| Mann Brenda | VP of Research & Development | 08/04/2020 | 378 |
| FROM STEPHEN | President and CEO | 07/02/2020 | 3,013 |
| MANZO MICHAEL P. | VP of Engineering | 07/02/2020 | 468 |
| Romano Sarah | Chief Financial Officer | 07/02/2020 | 468 |
| Mann Brenda | VP of Research & Development | 07/02/2020 | 453 |
| FROM STEPHEN | President and CEO | 06/03/2020 | 3,204 |
| Romano Sarah | Chief Financial Officer | 06/03/2020 | 480 |
| Mann Brenda | VP of Research & Development | 06/03/2020 | 480 |
| MANZO MICHAEL P. | VP of Engineering | 06/03/2020 | 480 |
| Romano Sarah | Chief Financial Officer | 05/05/2020 | 474 |
| Mann Brenda | VP of Research & Development | 05/05/2020 | 576 |
| MANZO MICHAEL P. | VP of Engineering | 05/05/2020 | 474 |
| FROM STEPHEN | President and CEO | 05/05/2020 | 3,147 |
| Mann Brenda | VP of Research & Development | 04/02/2020 | 606 |
| FROM STEPHEN | President and CEO | 04/02/2020 | 3,330 |
| MANZO MICHAEL P. | VP of Engineering | 04/02/2020 | 606 |
| Romano Sarah | Chief Financial Officer | 04/02/2020 | 606 |
| FROM STEPHEN | President and CEO | 03/09/2020 | 3,560 |
| Mann Brenda | VP of Research & Development | 03/09/2020 | 650 |
| MANZO MICHAEL P. | VP of Engineering | 03/09/2020 | 651 |
| Romano Sarah | Chief Financial Officer | 03/09/2020 | 651 |
| ARMISTICE CAPITAL, LLC | Director | 02/10/2020 | 72,480 |
| ARMISTICE CAPITAL, LLC | Director | 02/06/2020 | 67,980 |
| FROM STEPHEN | President and CEO | 02/04/2020 | 3,504 |
| MANZO MICHAEL P. | VP of Engineering | 02/04/2020 | 654 |
| Mann Brenda | VP of Research & Development | 02/04/2020 | 654 |
| Romano Sarah | Chief Financial Officer | 02/04/2020 | 654 |
| FROM STEPHEN | President and CEO | 01/03/2020 | 6,950 |
| Mann Brenda | VP of Research & Development | 01/03/2020 | 1,133 |
| Romano Sarah | Chief Financial Officer | 01/03/2020 | 1,133 |
| MANZO MICHAEL P. | VP of Engineering | 01/03/2020 | 1,133 |
| Romano Sarah | Chief Financial Officer | 12/18/2019 | 753 |
| Mann Brenda | VP of Research & Development | 12/18/2019 | 753 |
| MANZO MICHAEL P. | VP of Engineering | 12/18/2019 | 753 |
| FROM STEPHEN | President and CEO | 12/18/2019 | 4,871 |
| GOLDBERG MORTON | Director | 12/06/2019 | 13,590 |
| GOLDBERG MORTON | Director | 11/12/2019 | 8,584 |
| Mann Brenda | VP of Research & Development | 11/05/2019 | 412 |
| Romano Sarah | Chief Financial Officer | 11/05/2019 | 416 |
| FROM STEPHEN | President and CEO | 11/05/2019 | 2,579 |
| MANZO MICHAEL P. | VP of Engineering | 11/05/2019 | 417 |
| Romano Sarah | Chief Financial Officer | 10/09/2019 | 573 |
| FROM STEPHEN | President and CEO | 10/09/2019 | 3,493 |
| Mann Brenda | VP of Research & Development | 10/09/2019 | 574 |
| MANZO MICHAEL P. | VP of Engineering | 10/09/2019 | 579 |
| ARMISTICE CAPITAL, LLC | Director | 09/30/2019 | 15,613 |
| ARMISTICE CAPITAL, LLC | Director | 09/29/2019 | 1,875,000 |
| FROM STEPHEN | President and CEO | 08/06/2019 | 2,143 |
| Romano Sarah | Chief Financial Officer | 08/06/2019 | 346 |
| MANZO MICHAEL P. | VP of Engineering | 08/06/2019 | 346 |
| Mann Brenda | VP of Research & Development | 08/06/2019 | 345 |
| Wirostko Barbara | Chief Medical Officer | 08/06/2019 | 345 |
| Romano Sarah | Chief Financial Officer | 07/15/2019 | 1,534 |
| Romano Sarah | Chief Financial Officer | 07/12/2019 | 1,551 |
| Romano Sarah | Chief Financial Officer | 07/11/2019 | 1,584 |
| MANZO MICHAEL P. | VP of Engineering | 07/15/2019 | 1,534 |
| MANZO MICHAEL P. | VP of Engineering | 07/12/2019 | 1,551 |
| MANZO MICHAEL P. | VP of Engineering | 07/11/2019 | 1,584 |
| Wirostko Barbara | Chief Medical Officer | 07/15/2019 | 1,512 |
| Wirostko Barbara | Chief Medical Officer | 07/12/2019 | 1,529 |
| Wirostko Barbara | Chief Medical Officer | 07/11/2019 | 1,561 |
| FROM STEPHEN | President and CEO | 07/15/2019 | 9,891 |
| FROM STEPHEN | President and CEO | 07/12/2019 | 10,002 |
| FROM STEPHEN | President and CEO | 07/11/2019 | 10,214 |
| Mann Brenda | VP of Research & Development | 07/15/2019 | 1,480 |
| Mann Brenda | VP of Research & Development | 07/12/2019 | 1,496 |
| Mann Brenda | VP of Research & Development | 07/11/2019 | 1,528 |
| ARMISTICE CAPITAL, LLC | Director | 03/29/2019 | 92,439 |
| ARMISTICE CAPITAL, LLC | Director | 03/28/2019 | 40,551 |
| ARMISTICE CAPITAL, LLC | Director | 03/27/2019 | 42,226 |
| ARMISTICE CAPITAL, LLC | Director | 12/11/2018 | 12,842 |
| ARMISTICE CAPITAL, LLC | Director | 12/10/2018 | 27,474 |
| ARMISTICE CAPITAL, LLC | Director | 11/16/2018 | 83,724 |
| ARMISTICE CAPITAL, LLC | Director | 11/15/2018 | 55,003 |
| ARMISTICE CAPITAL, LLC | Director | 11/14/2018 | 22,668 |
| Wirostko Barbara | Chief Medical Officer | 06/08/2018 | 3,780 |
| Wirostko Barbara | Chief Medical Officer | 06/07/2018 | 4,992 |
| Wirostko Barbara | Chief Medical Officer | 06/07/2018 | 1,152 |
| Wirostko Barbara | Chief Medical Officer | 06/08/2018 | 3,780 |
| Wirostko Barbara | Chief Medical Officer | 06/07/2018 | 1,152 |
| ARMISTICE CAPITAL, LLC | Director | 05/29/2018 | 23,317 |
| ARMISTICE CAPITAL, LLC | Director | 05/25/2018 | 10,116 |
| ARMISTICE CAPITAL, LLC | Director | 05/18/2018 | 959 |
| ARMISTICE CAPITAL, LLC | Director | 05/14/2018 | 8,417 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/11/2018 | 26,438 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/10/2018 | 12,982 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/09/2018 | 51,571 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/08/2018 | 17,718 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/07/2018 | 6,888 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 05/04/2018 | 38,866 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/25/2018 | 46,250 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/26/2018 | 43,016 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/20/2018 | 261,701 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/19/2018 | 599,299 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/18/2018 | 370,158 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/13/2018 | 2,466,649 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/17/2018 | 837,670 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 04/16/2018 | 435,731 |
| Romano Sarah | Chief Financial Officer | 12/29/2017 | 11,982 |
| Wirostko Barbara | Chief Medical Officer | 12/29/2017 | 12,479 |
| Mann Brenda | VP of Research & Development | 12/29/2017 | 6,789 |
| FROM STEPHEN | President and CEO | 12/29/2017 | 12,479 |
| Garanzini Michael | Chief Commercial Officer | 11/17/2017 | 16,050 |
| Wirostko Barbara | Chief Medical Officer | 09/14/2017 | 11,070 |
| Wirostko Barbara | Chief Medical Officer | 09/14/2017 | 1,464 |
| Wirostko Barbara | Chief Medical Officer | 09/15/2017 | 10,800 |
| Romano Sarah | Interim CFO | 08/15/2017 | 10,000 |
| FROM STEPHEN | President and CEO | 08/10/2017 | 12,875 |
| CHANEY PAUL G | Director | 06/02/2017 | 11,420 |
| MANZO MICHAEL P. | Vice President of Engineering | 05/15/2017 | 4,735 |
| Ventech Capital II | 10% Owner | 03/13/2017 | 12,385 |
| Wirostko Barbara | Chief Medical Officer | 03/07/2017 | 24,621 |
| GOLDBERG MORTON | Director | 03/06/2017 | 26,757 |
| Wirostko Barbara | Chief Medical Officer | 02/28/2017 | 108,420 |
| Wirostko Barbara | Chief Medical Officer | 02/28/2017 | 140,378 |
| GOLDBERG MORTON | Director | 02/27/2017 | 1,841 |
| FROM STEPHEN | President and CEO | 09/15/2016 | 22,338 |
| FROM STEPHEN | President and CEO | 06/30/2016 | 34,327 |
| GOLDBERG MORTON | Director | 06/15/2016 | 47,361 |
| Ventech Capital II | 10% Owner | 06/10/2016 | 46,333 |
| Ventech Capital II | 10% Owner | 06/09/2016 | 40,523 |
| Ventech Capital II | 10% Owner | 06/06/2016 | 32,684 |
| Ventech Capital II | 10% Owner | 06/08/2016 | 7,680 |
| Ventech Capital II | 10% Owner | 06/07/2016 | 55,060 |
| GOLDBERG MORTON | Director | 06/03/2016 | 21,879 |
| GOLDBERG MORTON | Director | 06/07/2016 | 2,473 |
| GOLDBERG MORTON | Director | 06/06/2016 | 18,040 |
| GOLDBERG MORTON | Director | 06/03/2016 | 15,690 |
| CHANEY PAUL G | Director | 02/19/2015 | 49,998 |
| Ventech Capital II | 10% Owner | 02/19/2015 | 1,013,334 |
| Ventech Capital II | 10% Owner | 02/19/2015 | 616,662 |
| NATIXIS PRIVATE EQUITY | 10% Owner | 02/19/2015 | 410,092 |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% Owner | 02/19/2015 | 580,415 |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% Owner | 02/19/2015 | 2,200,002 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR AB ACTIVE ETFS INC
LOADING...